| P50 | author | Hanah Mesallati | Q64357699 |
| | Ramin Dubey | Q85709454 |
| P2093 | author name string | Nathaniel J Traaseth | |
| | Paramjit S Arora | |
| | Bogdan Z Olenyuk | |
| | Brooke Bullock Lao | |
| | Swati Kushal | |
| | Laura K Henchey | |
| P2860 | cites work | HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing | Q24291102 |
| | Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway | Q24299670 |
| | Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1 alpha | Q24534120 |
| | Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis | Q24608039 |
| | Near IR heptamethine cyanine dye-mediated cancer imaging | Q24616262 |
| | Antitumor activity of a pyrrole-imidazole polyamide | Q24628320 |
| | Systematic analysis of helical protein interfaces reveals targets for synthetic inhibitors | Q24630804 |
| | Direct inhibition of the NOTCH transcription factor complex | Q24634015 |
| | Structural basis for Hif-1 alpha /CBP recognition in the cellular hypoxic response | Q27638869 |
| | Targeting HIF-1 for cancer therapy | Q27860504 |
| | Recognition of the DNA minor groove by pyrrole-imidazole polyamides | Q28182798 |
| | CREB-binding protein and p300 in transcriptional regulation | Q28209056 |
| | Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch | Q28217194 |
| | RETRACTED: Lysyl oxidase is essential for hypoxia-induced metastasis | Q28236828 |
| | Proteases universally recognize beta strands in their active sites | Q28238770 |
| | Peptidomimetic targeting of critical androgen receptor-coregulator interactions in prostate cancer | Q28291526 |
| | Reaching for high-hanging fruit in drug discovery at protein-protein interfaces | Q29547258 |
| | Molecular Recognition of Protein Surfaces: High Affinity Ligands for the CBP KIX Domain | Q31026926 |
| | Molecular mechanism of hypoxia-inducible factor 1alpha -p300 interaction. A leucine-rich interface regulated by a single cysteine | Q31527917 |
| | CBP/p300 TAZ1 domain forms a structured scaffold for ligand binding | Q34383065 |
| | Transcription factors as targets for cancer therapy | Q34932264 |
| | Assessing helical protein interfaces for inhibitor design | Q35201483 |
| | A complex task? Direct modulation of transcription factors with small molecules | Q35642431 |
| | An orthosteric inhibitor of the Ras-Sos interaction | Q35854216 |
| | Solid-phase synthesis of short α-helices stabilized by the hydrogen bond surrogate approach | Q36074865 |
| | Regulation of angiogenesis by hypoxia-inducible factor 1. | Q36485190 |
| | Intrinsic disorder in transcription factors | Q36882145 |
| | Repression of DNA-binding dependent glucocorticoid receptor-mediated gene expression | Q37348402 |
| | Regulation of angiogenesis by oxygen and metabolism. | Q37393186 |
| | Epidithiodiketopiperazines block the interaction between hypoxia-inducible factor-1alpha (HIF-1alpha) and p300 by a zinc ejection mechanism | Q37446834 |
| | Direct inhibition of hypoxia-inducible transcription factor complex with designed dimeric epidithiodiketopiperazine | Q37486398 |
| | Transcriptional switches: chemical approaches to gene regulation | Q37690520 |
| | Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist | Q37695740 |
| | Inhibition of α-helix-mediated protein-protein interactions using designed molecules | Q38082945 |
| | Suppression of tumor growth by designed dimeric epidithiodiketopiperazine targeting hypoxia-inducible transcription factor complex. | Q39187272 |
| | Inhibition of hypoxia‐inducible transcription factor complex with designed epipolythiodiketopiperazine | Q39649725 |
| | Confluence-dependent resistance to doxorubicin in human MDA-MB-231 breast carcinoma cells requires hypoxia-inducible factor-1 activity | Q40173211 |
| | Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia | Q40835443 |
| | Modulating hypoxia-inducible transcription by disrupting the HIF-1-DNA interface | Q41857906 |
| | Inhibition of hypoxia inducible factor 1-transcription coactivator interaction by a hydrogen bond surrogate alpha-helix | Q41978285 |
| | Amphipathic small molecules mimic the binding mode and function of endogenous transcription factors | Q41993123 |
| | Three conformational states of the p300 CH1 domain define its functional properties | Q44553272 |
| | Development of a hypoxia-responsive vector for tumor-specific gene therapy | Q45866583 |
| | A hydrogen bond surrogate approach for stabilization of short peptide sequences in alpha-helical conformation | Q46481219 |
| | Identification of hypoxically inducible mRNAs in HeLa cells using differential-display PCR. Role of hypoxia-inducible factor-1. | Q48058964 |
| | Measuring response in solid tumors: unidimensional versus bidimensional measurement | Q74628193 |
| | Inhibition of HIV-1 fusion by hydrogen-bond-surrogate-based alpha helices | Q80559914 |
| P433 | issue | 39 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hypoxia | Q105688 |
| P304 | page(s) | 15602-15607 | |
| P577 | publication date | 2013-09-09 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Protein domain mimetics as in vivo modulators of hypoxia-inducible factor signaling | |
| P478 | volume | 110 | |